Protagenic Therapeutics, Inc.\new
Developing novel peptide drugs to treat stress-related neuropsychiatric & CNS disorders.
PTIX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US74365N2027 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 149 FIFTH AVENUE, 10010 NEW YORK
- Website:
- https://protagenic.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Protagenic Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a platform of first-in-class treatments for stress-related neuropsychiatric and central nervous system (CNS) disorders. The company's core technology leverages Teneurin C-terminal Associated Peptides (TCAPs), a novel class of neuropeptides designed to regulate the brain's stress response at a cellular level. Its lead drug candidate, PT00114, is in clinical development for various indications, including mood disorders, depression, and substance abuse. Protagenic aims to address unmet clinical needs by directly modulating the brain's maladaptive responses to stress. The company has announced a business combination with Phytanix to form a new entity, Phytanix, Inc., combining their respective drug development pipelines.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Protagenic Therapeutics, Inc.\new filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Protagenic Therapeutics, Inc.\new
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Protagenic Therapeutics, Inc.\new via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
